Predictions
Biolife Solutions Inc
Start price
Target price
Perf. (%)
€2.90
05.07.17
05.07.17
€3.10
14.07.17
14.07.17
27.25%
14.07.17
14.07.17
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€9.68
05.07.17
05.07.17
€13.50
02.11.17
02.11.17
-18.61%
02.11.17
02.11.17
Airbus Group SE
Start price
Target price
Perf. (%)
€73.81
05.07.17
05.07.17
€89.00
26.09.17
26.09.17
5.76%
26.09.17
26.09.17
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
Harley-Davidson Inc.
Start price
Target price
Perf. (%)
€49.40
05.07.17
05.07.17
€54.12
10.11.17
10.11.17
-13.79%
10.11.17
10.11.17
Nanobiotix
Start price
Target price
Perf. (%)
€20.70
03.07.17
03.07.17
€22.00
19.12.17
19.12.17
-38.60%
19.12.17
19.12.17
Could be worthwhile Investment >10% per year
Nanobiotix
Start price
Target price
Perf. (%)
€20.70
03.07.17
03.07.17
€22.00
19.12.17
19.12.17
-38.60%
19.12.17
19.12.17
Could be worthwhile Investment >10% per year
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.24
30.06.17
30.06.17
€23.45
03.12.18
03.12.18
8.65%
03.12.18
03.12.18
Austria Microsystems AG
Start price
Target price
Perf. (%)
€55.99
30.06.17
30.06.17
€63.00
12.07.17
12.07.17
12.54%
12.07.17
12.07.17
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Groupe Partouche S.A.
Start price
Target price
Perf. (%)
€29.15
29.06.17
29.06.17
€40.00
23.10.17
23.10.17
13.58%
23.10.17
23.10.17
Groupe Partouche S.A.
Start price
Target price
Perf. (%)
€29.15
29.06.17
29.06.17
€40.00
23.10.17
23.10.17
13.58%
23.10.17
23.10.17
Berkshire Hathaway Inc. A
Start price
Target price
Perf. (%)
€229,604
28.06.17
28.06.17
€450,000
04.11.21
04.11.21
63.11%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Fair valuation
Top Rating
Very positive Cash Flow expected
Medtronic plc
Start price
Target price
Perf. (%)
€78.00
28.06.17
28.06.17
€85.00
10.11.17
10.11.17
-12.23%
10.11.17
10.11.17
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€49.88
27.06.17
27.06.17
€43.14
19.04.20
19.04.20
-88.43%
19.04.20
19.04.20
Barrick Gold Corp
Start price
Target price
Perf. (%)
€10.97
21.06.17
21.06.17
-
04.11.21
04.11.21
48.87%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
High dividend yield expected
Good rating
Undervalued
